© Copyright Acquisition International 2024 - All Rights Reserved.

Article Image - CEO of the Month, Belgium: Jan De Backer, FLUIDDA
Posted 28th October 2015

CEO of the Month, Belgium: Jan De Backer, FLUIDDA

FLUIDDA develop proprietary diagnostics for lung diseases, such as asthma, chronic obstructive pulmonary disease and lung fibrosis.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

CEO of the Month, Belgium: Jan De Backer, FLUIDDA

CEO of the Month – Jan De Backer, FLUIDDA

Image

FLUIDDA develop proprietary diagnostics for lung diseases, such as asthma, chronic obstructive pulmonary disease (COPD) and lung fibrosis. The technology, called Functional Respiratory Imaging or FRI is a combination of high-resolution CT scans and computer methods that simulate the flow in the lungs.

FRI provides an unparalleled insight into how the lungs of specific patients work. Airways, blood vessels and airflow can be visualised and analysed in great detail. In addition, FRI can determine where inhaled drug particles end up in the lungs of patients. FLUIDDA uses FRI to help pharmaceutical companies develop better drugs for lung diseases, faster and cheaper. Additionally the firm also work with individual physicians to help them to select the most appropriate treatment for specific patients, which is unusual as it requires a more costly trial and error approach not usually adopted by other firms in the industry.

Jan started at the company in 2005 and has since helped the firm to differentiate itself from its competitors by becoming active in the R&D phase of development, where their technology can inform pharmaceutical and biotech companies very quickly whether the compound is worthwhile pursuing.

The firm are also involved in the marketing phase where their visualisations of the mode of action of the drug, based on real patient data, is used to show the added value of the drug or device to doctors, insurance companies as well as being active in clinical practice where the company can leverage the knowledge from the clinical trials to assist the doctor in selecting the most optimal treatment for individual patients based on the patient specific characteristics.

Jan explained the firm’s vision and how he ensures that this is upheld by everyone within the firm.
“My role as CEO has evolved over the years. I started the company ten years ago and at that time the emphasis of the company was mainly on the development of the technology. We had to perform our clinical validation trials and ensure the technology became scalable. Gradually my role became more general management with the focus on international expansion (we opened an office in India in 2010 and in the US in 2012) and developing a vision for sustained growth.

“This vision, nowadays, revolves very much around levering modern day technology to improve the efficiency, including the cost/benefit ratio, of many facets of the healthcare system. This includes drug development, treatment optimization in clinical practice and even patient education. We feel that a system where all stakeholders align around the patient interest is a system with the highest probability of success to improve the efficiency of the healthcare system.

“Communication is key to ensure that everyone in the company is aware of our vision and that they do whatever is needed to support it. Despite a very busy travel schedule I try to keep in touch with the teams in the different locations as much as possible. Every month I update the company, including our directors, on the latest developments. This is good opportunity to either welcome people to the team, congratulate the teams on the performance or to caution for potential threats in the foreseeable future. Our people know that if there is an issue they can always bring it my attention and I will do whatever I can to resolve it.”

Being a technology company in the healthcare industry means being exposed to a number of rapidly changing markets, with regulation, technology and health innovation constantly evolving. Jan described the market and how the changes affected FLUIDDA.

“I strongly believe that we are on the verge of a revolution in healthcare. We see important stakeholders such as governments, patient advocacy groups and a new generation of doctors all converge around implementing new technologies to make the system more efficient. This is largely driven by the budgetary constraints due to the exponential increase in the healthcare costs and the additional challenges in healthcare due to the aging population.

“As a company we have invested greatly in being able to translate, often complex, technology into a format fit for the medical world. We do not expect doctors to become technical experts but we rather make our technology as accessible as possible for the physician. We like to harness the power of modern technology such as high-performance computing and big data and convert that into personalised medicine in collaboration with the medical professionals. FLUIDDA aims to do that in a sustainable manner, which should ensure our position as a leading edge technology partner.”

Overall, Jan made it clear that these changes in the industry, now and in the future, would keep the firm at the very height of innovation.

“This is an exciting time for healthcare. There is a high need to change to keep the system affordable. At the same time, the level of implementation of modern technology (cloud services, home monitoring, personalised diagnostics, etc) is relatively low. Companies that manage to implement this type of new technology will have a bright future. Within FLUIDDA we will strive to be one of those companies by continuing to transform excellent science into readyto- use applications for doctors and researchers.”

Company: FLUIDDA

Name: Jan De Backer

Email: info@FLUIDDA.com

Web: www.FLUIDDA.com

Address: Groeningenlei 132,

2550 Kontich, Belgium

Telephone: +32 3 450 87 20

Categories: Leadership


You Might Also Like
Read Full PostRead - Eye Icon
Over 10,000 COVID-19 Phishing Scams Reported to HMRC During Height of Pandemic
News
21/08/2020Over 10,000 COVID-19 Phishing Scams Reported to HMRC During Height of Pandemic

Her Majesty's Revenue and Customs (HMRC) is investigating 10,428 email, SMS, social media, and phone scams exploiting the Covid-19 pandemic, according to official figures.

Read Full PostRead - Eye Icon
Innovative, Practical, Cost-Effective Forklifts
News
18/07/2022Innovative, Practical, Cost-Effective Forklifts

TASK Forklifts designs, engineers and manufactures a range of pedestrian walkie stackers for the materials handling industry. Acquisition International magazine has recognised the company for its award in Most Outstanding Forklifts Manufacturer 2022 – Austra

Read Full PostRead - Eye Icon
Taking a Bite Out of Apple
Innovation
24/06/2015Taking a Bite Out of Apple

Taylor Swift trumps technology giant, Apple, as they back down over royalties row.

Read Full PostRead - Eye Icon
Advantages of ACH Transfers
News
08/07/2022Advantages of ACH Transfers

Advantages of ACH Transfers ACH Transfers or eChecks help eliminate transaction problems for businesses and their clients. Paper checks are inconvenient because clients need to remember to pay the bill, and businesses must visit the bank each time they want to

Read Full PostRead - Eye Icon
Why We Need Happy Employees
Leadership
28/05/2015Why We Need Happy Employees

We recognise that happy employees are the secret to a healthy bottom Line within a business. Recent studies represent the link between happy employees and customer satisfaction.

Read Full PostRead - Eye Icon
Brum Costa: Specialists in Finance and Tax Law
Finance
12/01/2018Brum Costa: Specialists in Finance and Tax Law

Brum Costa Abogados specialises in customised consultancy services in management of financial risk and compliance, regulatory advice on banking and financial issues, tax compliance and prevention of money laundering.

Read Full PostRead - Eye Icon
Doing Business Overseas
Finance
05/05/2016Doing Business Overseas

Landing Dione is a Consultant, who specialises in real estate management and strategies, quality management, value chain management, project management and business development.

Read Full PostRead - Eye Icon
Hyundai Heavy Industries and Scania Announce Partnership
M&A
20/04/2015Hyundai Heavy Industries and Scania Announce Partnership

Scania will supply engines for next-generation large excavators and wheel loaders made by Hyundai Heavy Industries’ Construction Equipment division, under a new partnership.

Read Full PostRead - Eye Icon
Enhancing Workplace Efficiency and Security with Smart Lockers
News
22/08/2023Enhancing Workplace Efficiency and Security with Smart Lockers

In today’s rapidly evolving workplace landscape, the integration of technology has revolutionized various aspects of business operations. One such innovation that has gained remarkable prominence is the utilization of smart lockers. These intelligent sto



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow